1. Scrip
  2. >>Business

Janssen India MD To Depart

 
• By Anju Ghangurde

Significant leadership change is underway at J&J India, with Janssen India chief Sanjiv Navangul on his way out. He will be succeeded by senior J&J hand, Sarthak Ranade, who will need to handle some delicate issues pertaining to Sirturo while also keeping the flow of innovative products from the parent company to India going.

Leadership
SIGNIFICANT LEADERSHIP CHANGES ARE UNDERWAY AT J&J INDIA

Janssen India chief Sanjiv Navangul is moving on after an eventful stint at the helm of the US multinational’s operations in India. Sarthak Ranade, who has been with Janssen for over a decade in various leadership positions, will succeed Navangul as managing director of Janssen India.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Abeona Sets $3.1m Price For Rare Skin Disorder Gene Therapy

 
• By Joseph Haas

Abeona plans to offer an outcomes-based payment model for Zevaskyn, which likely will see complementary use with Krystal’s Vyjuvek in recessive dystrophic epidermolysis bullosa patients.

Another CRL Prompts Questions About Regeneron’s Regulatory Operations

 
• By Alaric DeArment

CEO Len Schleifer explained on the company’s Q1 earnings call that most of the complete response letters the company has received related to third-party suppliers, not efficacy or safety.

Novartis Doubles Down On Push For Higher Drug Prices In Europe

 
• By Jessica Merrill

CEO Vas Narasimhan urged European governments to spend more to support drug innovation during Novartis's first-quarter results call.